Correction to: Emergence of knock-down resistance in the Anopheles gambiae complex in the Upper River Region, The Gambia, and its relationship with malaria infection in children
verfasst von:
Anne L. Wilson, Margaret Pinder, John Bradley, Martin J. Donnelly, Majidah Hamid‑Adiamoh, Lamin B. S. Jarju, Musa Jawara, David Jeffries, Ballah Kandeh, Emily J. Rippon, Kolawole Salami, Umberto D’Alessandro, Steven W. Lindsay
Unfortunately, the original article [1] contained an error mistakenly carried forward by the Production department handling this article whereby some figures and their captions were interchanged. The correct figures (Figs. 1, 2, 3, 4, 5) and captions are presented in this erratum. The original article has also been updated to reflect this correction.
Fig. 1
Spatial distribution of 32 entomological sampling sites in the Upper River Region of The Gambia, in relation to landcover/use
Fig. 2
Number of An. arabiensis, An. gambiae s.s., An. coluzzii and hybrid (An. gambiae s.s. × An. coluzzii) caught using CDC light traps per round during 2010 and 2011 (IRS using DDT was administered between 15–28 July 2010 and 20 July–9 August 2011)
Fig. 3
Distribution of members of the An. gambiae s.l. complex in the study area during 2010 (a) and 2011 (b) transmission seasons. Pie charts show percentage composition of species of An. gambiae s.l. complex at CDC light trap sampling sites (excluding sampling sites with less than 10 mosquitoes caught in total across each transmission season)
Fig. 4
Distribution of members of the An. gambiae s.l. species complex (excluding An. arabiensis) in the study area during 2010 (a) and 2011 (b) transmission seasons. Pie charts show percentage An. gambiae s.l. species composition (excluding An. arabiensis) at CDC light trap sampling sites (excluding sampling sites with less than 10 mosquitoes caught in total across each transmission season)
Fig. 5
Vgsc-1014 mutation status of An. gambiae s.l. in the study area during 2010 (a) and 2011 (b) transmission seasons. Pie charts show percentage wildtype, homozygous and heterozygous Vgsc-1014F and Vgsc-1014S mutations in An. gambiae s.l. complex at CDC light trap sampling sites (excluding sampling sites with less than 10 mosquitoes caught in total across each transmission season)
×
×
×
×
×
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anzeige
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Correction to: Emergence of knock-down resistance in the Anopheles gambiae complex in the Upper River Region, The Gambia, and its relationship with malaria infection in children
verfasst von
Anne L. Wilson Margaret Pinder John Bradley Martin J. Donnelly Majidah Hamid‑Adiamoh Lamin B. S. Jarju Musa Jawara David Jeffries Ballah Kandeh Emily J. Rippon Kolawole Salami Umberto D’Alessandro Steven W. Lindsay
Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.
Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.
Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.
Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
